Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
The BBRC participates in a study to facilitate early diagnosis of Alzheimer's with a blood test
The research center of the Pasqual Maragall Foundation has made the first visit of the EAPP study in July 2023.
Spain is among the top 10 countries in the world in Alzheimer's research
Among the most prominent research centers in Spain is the Barcelonaβeta Brain Research Center (BBRC) of the Pasqual Maragall Foundation.
Presented at AAIC the results of a new drug that would slow cognitive decline
According to the data presented, and simultaneously published in JAMA, the treatment with donanemab will significantly reduce the levels of amyloid plaque.
The BBRC participates in AAIC 2023 with eight talks and thirty posters
During the meeting, the teams will disseminate their research findings to the international scientific community.
The United States approves the commercialisation of lecanemab, a drug that could slow the progression of Alzheimer’s
In order to know the situation of the drug in Europe, it will be necessary to wait for the resolution of the European Medicines Agency.
"More resources for better research": the 2022 Report of the Pasqual Maragall Foundation and the BBRC is now available
The document collects the most outstanding annual information on the scientific, social and economic activity of the two entities.
Barcelona hosts for the first time a specialised course on brain organoids
The program includes a day at the BBRC facilities, in which attendees will carry out a practical session on protein detection in organoid tissue.
European project PROMINENT will enhance diagnosis and treatment of neurodegenerative diseases
The Barcelonaβeta Brain Research Center will contribute to the development and validation of prediction models and diagnostic algorithms for the digital platform.
The PROAD project of the BBRC receives a secondary award of the Scientific Research Award for Health from the hna Foundation
The study seeks to identify proteomic profiles in blood that can predict cognitive decline in people with an increased risk of developing Alzheimer's disease.
